Evidence mapPaperPMID 32845571Full record

ArticleClinical obesity2020

Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centre.

William P Martin, Jessica Bauer, John Coleman, Ludmilla Dellatorre-Teixeira, Janice L V Reeve, Patrick J Twomey, Neil G Docherty, Aisling O'Riordan, Alan J Watson, Carel W le Roux and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical obesity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  3. The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes Mellitus.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

William P MartinDiabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0001-7005-3966
Jessica BauerDiabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin, Ireland.
John ColemanDepartment of Nephrology, St. Vincent's University Hospital, Dublin, Ireland.
Ludmilla Dellatorre-TeixeiraDiabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin, Ireland.
Janice L V ReeveDepartment of Clinical Chemistry, St. Vincent's University Hospital, Dublin, Ireland.
Patrick J TwomeyDepartment of Clinical Chemistry, St. Vincent's University Hospital, Dublin, Ireland.
Neil G DochertyDiabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0002-0961-2607
Aisling O'RiordanDepartment of Nephrology, St. Vincent's University Hospital, Dublin, Ireland.
Alan J WatsonDepartment of Nephrology, St. Vincent's University Hospital, Dublin, Ireland.
Carel W le RouxDiabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin, Ireland.
John HolianDepartment of Nephrology, St. Vincent's University Hospital, Dublin, Ireland.
St. Vincent's University Hospital · IEUniversity College Dublin · IE

Funding

European Foundation for the Study of Diabetes BI 2017_3Health Research Board 203930/B/16/ZMedicinska Forskningsrådet 2015-02733Science Foundation Ireland 12/YI/B2480Wellcome TrustWellcome Trust 203930/B/16/Z
6 · The paper itself

Abstract

Obesity is a treatable risk factor for chronic kidney disease progression. We audited the reporting of body-mass index in nephrology outpatient clinics to establish the characteristics of individuals with obesity in nephrology practice. Body-mass index, clinical information and biochemical measures were recorded for patients attending clinics between 3

Indexed as

Body Mass IndexAntihypertensive AgentsBiomarkersCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateHumansHypertensionHypoglycemic AgentsMaleMedical AuditMiddle AgedNephrologyObesityProteinuriaAntihypertensive AgentsBiomarkersHypoglycemic Agentschronic kidney diseasediabetes mellitusdiabetic kidney diseaseobesityoverweight

Identifiers

PMID32845571
PMCPMC7685118
OpenAlexW3081168542

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.